Abstract
Independent 5-year pharmaceutical and healthcare industry forecasts for
Algeria.
Original pharmaceutical and healthcare market research and pharmaceutical and
healthcare sector trend analysis for the Algerian pharmaceutical and
healthcare industry.
Competitive intelligence, Algerian pharmaceutical and healthcare company
rankings and SWOT analyses on international and domestic pharmaceutical and
healthcare companies in the Algerian market.
The Algeria Pharmaceuticals and Healthcare Report has been researched at
source and features the latest available data and forecasts to end- covering
drugs and healthcare expenditure, the prescription, OTC and generics markets,
and foreign trade; company rankings and competitive landscapes including
multinational and national drugs companies; and analysis of latest industry
news, trends and regulatory developments.
Business Monitor International' s Algeria Pharmaceuticals and Healthcare Report
provides industry professionals, market investors and corporate and financial
services analysts with independent forecasts and competitive intelligence on
the Algerian pharmaceutical and healthcare industry.
Key Benefits of Report
- Benchmark BMI' s Independent 5-year Pharmaceutical and Healthcare Industry
Forecasts on Algeria to test other views - a key input for successful
budgeting and strategic business planning in the Algerian pharmaceutical and
healthcare market.
- Target Business Opportunities & Risks in the Algerian Pharmaceutical and
Healthcare Sector through our reviews of latest industry trends, regulatory
changes and major deals, projects and investments in Algeria.
- Exploit The Latest Competitive Algerian Pharmaceutical and Healthcare
Intelligence & company SWOTS on your competitors and peers through company
rankings by sales, market share and ownership structure - includes
multi-national and national companies in Algeria.
Coverage
Executive Summary & Industry SWOT
An at-a-glance perspective on latest regulatory developments, key forecast
indicators and major corporate developments, covering the prescription, OTC
and generics markets. The SWOT outlines strategic factors which affect BMI' s
forecast analysis, and taken together with BMI' s Economic and Business
Environment SWOTS, give a complete overview of market climate.
Market Summary
Outline of market characteristics, growth factors, leading therapeutic
segments and a competitivness of the market.
Regulatory Regime
Guide to and analysis of country intellectual property developments and
pricing & reimbursement issues, which constitute the regulatory make-up of the
market.
Industry Developments
Focus on government healthcare reforms, epidemiological trends, company M&As,
product launches, market entries, FDI activity, R&D and patent legislation.
BMI 5-Year Industry Forecast
5-Year Forecasts to end- for all key industry indicators (see list below),
supported by explicit assumptions, plus analysis of key downside risks to the
main forecast, including:
- Drug market expenditure (US$bn); drug expenditure per capita (US$); as %
of gdp
- Prescription drug market (US$bn)/as % of total market; sales by alimentary
tract/metabolism; antibiotics, cardiovascular, central nervous system,
oncology, musculoskeletal and respiratory system
- OTC market (US$bn)/as % of total market (sales by analgesic, cough and
cold, digestives, skin treatments, vitamins and minerals)
- Generics market (US$bn)/ as % of total market
- Health expenditure (US$bn, % of gdp and per capita); public sector health
expenditure as % of total; number of hospitals; beds, hospital admissions,
doctors, births and deaths per 000 population
Forecasts based on bespoke BMI economic modelling, using historical data sets
of macroeconomic and industry variables to derive rigorous statistical
relationships, anchored in advanced linear regression techniques.
BMI 5-Year Macroeconomic Forecasts
BMI forecasts for all headline macroeconomic indicators, including: Nominal
and real GDP, % real GDP growth, % private consumption growth, % industrial
output growth, % consumer price index, % GDP price deflator, exports, imports,
trade balance, current account balance, foreign direct investment, exchange
rate against US$, government expenditure, external debt
Competitive Landscape & Profiles
Intelligence on the market position of major MNC power houses and indigenous
companies. BMI profiles key research-based companies. Company SWOTS are
provided for all key strategic players, complete with a company activity
overview, its leading products and analysis of business opportunities.
| 
View Cart
